Zhejiang Cancer Hospital
🇨🇳China
Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis
Phase 3
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- Drug: Saline
- First Posted Date
- 2018-10-25
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT03720340
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC
- First Posted Date
- 2018-09-19
- Last Posted Date
- 2018-09-19
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 180
- Registration Number
- NCT03678649
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
PET/MR in Locally Advanced Nasopharyngeal Carcinoma
Not Applicable
Recruiting
- Conditions
- PET/MRNasopharyngeal Carcinoma
- Interventions
- Diagnostic Test: PET/MR
- First Posted Date
- 2018-09-04
- Last Posted Date
- 2018-09-04
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT03657017
- Locations
- 🇨🇳
Xiaozhong Chen, Hangzhou, Zhejiang, China
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2018-12-07
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03647280
Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2018-12-10
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03647514
Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy
- Conditions
- Nasopharyngeal Carcinoma
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2018-08-27
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT03647527
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT03638648
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
- Conditions
- Febrile Neutropenia
- Interventions
- Drug: PEGCSF first level prophylactic useDrug: PEGCSF second level prophylactic use
- First Posted Date
- 2018-08-07
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT03618810
Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer
- Conditions
- Rectal NeoplasmsCirculating Tumor DNANeoadjuvant Therapy
- First Posted Date
- 2018-08-03
- Last Posted Date
- 2019-05-29
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT03615170
- Locations
- 🇨🇳
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients
- Conditions
- Nasopharyngeal Carcinoma
- Interventions
- Radiation: IMRTRadiation: TOMO
- First Posted Date
- 2018-07-17
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- Zhejiang Cancer Hospital
- Target Recruit Count
- 110
- Registration Number
- NCT03588403
- Locations
- 🇨🇳
Xiaozhong Chen, Hangzhou, Zhejiang, China
© Copyright 2025. All Rights Reserved by MedPath